BROOKE RUANE: Open Payments
NPI 1154895241 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,639 in 25 payments from 7 companies in 2025. Trend: 2023 $569 · 2024 $219 · 2025 $1,639
Consulting: $900Food & beverage: $694Travel & lodging: $46
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 18 | $1,286 |
| Pulmonx Corporation | 2 | $228 |
| Actelion Pharmaceuticals US, Inc. | 1 | $29 |
| Verona Pharma, Inc. | 1 | $28 |
| Averitas Pharma Inc. | 1 | $28 |
| Regeneron Healthcare Solutions, Inc. | 1 | $25 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: NUCALA, CHARTIS CATHETER, UPTRAVI, Ohtuvayre, QUTENZA, DUPIXENT, FASENRA.
Industry payments across PA — which companies pay providers there.
